Table A1.
Weeks | BBB | Rotarod | GRST | Weight |
---|---|---|---|---|
23 | p ≤ 0.0221 | p = 0.054 | p = 0.08 | p = 0.2 |
24 | p ≤ 0.003 | p ≤ 0.0018 | p ≤ 0.024 | p = 0.055 |
25 | p ≤ 0.003 | p ≤ 0.0000004 | p ≤ 0.000061 | p = 0.10 |
26 | p ≤ 0.003 | p ≤ 0.0000004 | p ≤ 0.000061 | p = 0.20 |
27 | p ≤ 0.004 | p ≤ 0.0035 | p ≤ 0.000013 | p = 0.09 |
28 | p ≤ 0.024 | p ≤ 0.04 | p ≤ 0.022 | p = 0.1 |
29 | p ≤ 0.05 | p ≤ 0.014 | p ≤ 0.04 | p = 0.2 |
At week 23 (highlighted by gray color) SOD1-rats started to manifest a motor function deficiency, which was considered as a disease onset; animals in this group were treated with NP-iPS at week 12. Statistical significance between the groups are marked by bold font.